Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $923.37, with a 24-hour trading volume of $10.51M. The asset's market cap is $825.28B, after moving 0.09% in the last day.
Tokenized Eli Lilly And Co is trading at $926.05, with a tokenized market cap of $5.08M and a 24-hour trading volume of $1.98M. The tokenized asset has moved -0.95% in the past 24 hours.